BioSpace News Archive

AUM Biosciences Pte. Ltd. announced today that their management team will participate in the BioCentury-BayHelix East-West BioPharma Summit in Redwood City, California and virtually.

Exactech announced today 510(k) clearance from the U.S. Food and Drug Administration to market the TriVerse™ primary knee system.

Outset Medical, Inc. today announced that it has entered into two senior secured credit facilities with investment affiliates managed by SLR Capital Partners, LLC (“SLR”) which collectively provide for borrowings of up to $300 million.

Vistagen today announced it will host a conference call and webcast on Thursday, November 10, 2022, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report financial results for its fiscal year 2023 second quarter ended September 30, 2022.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its third quarter 2022 financial results on Wednesday, November 9, 2022, after the markets close.

Keystone Laboratories, Inc. has announced that they will be offering a fully in-house Urinalysis and Urine Culture test panel.

Cambrian BioPharma announced that its CEO, James Peyer, has been selected as “BioTech Company CEO of the Year” in the second annual BioTech Breakthrough Awards, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe.

Advanced BioScience Laboratories announced it is one of three contractors awarded an Indefinite Delivery, Indefinite Quantity contract for “Manufacturing and Nonclinical Studies support for Development of Therapeutic Biotechnology Products for Neurological-related Disorders” by the NINDS of the NIH of the HHS.

A Medical Device Innovation Consortium (MDIC) program today released a new framework that provides U.S. medical device companies a systematic approach for patient-focused clinical trial design to better meet patient needs and priorities.

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its third quarter financial results for the period ended September 30, 2022, on Wednesday, November 9, 2022, after the market closes.